FDA Extends Comment Period for Risk Assessment of Animal Drug Residues in Milk

Citing stakeholder concerns over insufficient time to develop meaningful
submissions, the U.S. Food and Drug Administration (FDA) has
extended by 90 days the period in which to submit comments about the
agency’s risk assessment titled, “Multicriteria-Based Ranking Model for
Risk Management of Animal Drug Residues in Milk and Milk Products.”
FDA seeks suggestions for improving the specific criteria, scoring and
weighting scheme; selection of animal drugs evaluated; and transparency
of the risk assessment. Electronic or written submissions are now due by
October 27, 2015. See Federal Register, July 30, 2015.

Issue 573